MINUTES
About Minutes
Back to latest

EconomyYicura BioMed eyes IPO as CEO says Hong Kong biotech needs more patient capital

Hong Kong-based start-up Yicura BioMed is working towards a local IPO as soon as practicable. CEO Xian Jin says the city needs more patient capital and more talent able to commercialise research and development to sustain its biotechnology ecosystem.

biotechnologyIPOHong Kongstartup funding

SSouth China Morning Post★★☆☆☆2026-11-18 06:00Original

Yicura BioMed eyes IPO as CEO says Hong Kong biotech needs more patient capital
Yicura BioMed eyes IPO as CEO says Hong Kong biotech needs more patient capitalEconomy